Type 1 Diabetes

New Research Illustrates Underlying Mechanisms of COVID-19–Induced Diabetes

June 14th 2021, 9:30pm


National Institutes of Health–sponsored research examines the underlying cause of COVID-19–induced diabetes.

Increasing Rates of Metabolic Syndrome Seen in Children With T1D

June 9th 2021, 4:35pm


Results of a systematic review underscore implications of increased rates of metabolic syndrome among youth with type 1 diabetes.

Earlier Onset of T1D Linked With Poorer Glycemic Control

June 7th 2021, 6:00pm


Results of a nationwide study show earlier onset of type 1 diabetes (T1D) is associated with worse glycemic outcomes and presence of albuminuria.

CGM Improved Among Youth With T1D During COVID-19 Lockdown

June 4th 2021, 3:00pm


Results of a study conducted in California suggest some adolescents with type 1 diabetes (T1D) improved their glycemic control during the COVID-19 lockdown.

Glycemia, Blood Pressure Management Could Slow Cognitive Decline in Older Adults With T1D

June 2nd 2021, 5:00pm


Data from a longitudinal study reveal poor glycemic control and blood pressure management may contribute to cognitive decline in older patients with type 1 diabetes.

FDA Panel Supports Approving Teplizumab to Delay Type 1 Diabetes

May 28th 2021, 6:39pm


FDA panel members acknowledged the challenges and significant unmet need that patients with T1D face, along with the small size of the pivotal study.

Maternal Food Consumption Not Associated With Risk of IA, T1D

May 25th 2021, 1:00pm


A recent analysis of The Environmental Determinants of Diabetes in the Young study found maternal diet has no impact on type 1 diabetes and islet autoimmunity (IA) risk.

Understanding Cost Considerations Around Diabetes Technology in the T1D Community

May 19th 2021, 1:30pm


Results of a qualitative study outline widely held cost considerations regarding diabetes technology in the type 1 diabetes (T1D) community.

Dr Frank Martin on Increasing Regulator T1D Education

May 17th 2021, 2:00pm


Frank Martin, PhD, director of research at JDRF, discusses the organization's efforts to educate regulators about the disease.

FDA Clears Bigfoot BioMedical’s Smart Insulin Pen Caps

May 10th 2021, 4:36pm


The FDA cleared Bigfoot BioMedical's Diabetes Management System.